Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

38
3 Consumer Giants That Aren’t Dead Yet

1h investorplace
Back in March I began talking about the strength in consumer stocks, particularly brick-and-mortar names. Of course, most financial analysts had written off the brick and mortars as victims of the Amazon (NASDAQ:AMZN) era and the lingering impact on consumer behavior in the aftermath of the Great Recession.
DDS JWN AMZN M NFLX

0
5 Stocks in the Limelight After Recent Broker Rating Upgrade

7h zacks
The second-quarter reporting cycle, which is almost over, has unveiled an extremely rosy picture. With only a handful of companies left to report, the season is expected to end on a high, displaying significant earnings growth. Apart from recording bottom-line growth on a year-over-basis, a high proportion of companies have reported better-than-expected earnings per share.
DDS DK MLNX BGEPF BG ADM BZH BZMD

40
8 Best Retail Stocks That Just Went on Discount

2018-08-17 investorplace
One of the surprise sectors of 2018 is retail stocks. For several years, analysts have warned about impending doom for brick-and-mortars. Significantly declining foot traffic not only represented a major headwind, but skeptics pondered how retailers could fight back. Moreover, e-commerce, specifically Amazon (NASDAQ:AMZN) has disrupted the traditional marketplace.
DDS JWN TIF AMZN JCP ULTA AAPL M MSFT BOOT

5
Dillard's (DDS) Falls Despite Narrower Q2 Loss and Sales Beat

2018-08-17 zacks
Shares of Dillard's Inc. (DDS - Free Report) slumped 8.7% yesterday despite reporting top- and bottom-line beat for second-quarter fiscal 2018. Investors were probably not happy with the company’s loss per share results, which led to the decline in shares. Another reason behind the stock’s fall can be the general weakness seen in department store stocks, including Macy’s (M - Free Report) , which also fell considerably following its robust earnings show on Aug 15.
DDS HD OXY ROK

0
Dillard's (DDS) Reports Q2 Loss, Tops Revenue Estimates

2018-08-16 zacks
Dillard's (DDS - Free Report) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.58 per share a year ago. These figures are adjusted for non-recurring items.
DDS

53
Macy’s Thwacks the Earnings Print, But Still Gets Beat Down

2018-08-15 investorplace
Undoubtedly, one of the biggest surprises of this year is the retail industry. Specifically, iconic department stores like Macy’s (NYSE:M) have proven doubters wrong in the best possible way: making them rue the opportunity cost of not joining the fun.
PEI REG DDS JWN AMZN SRG JCP M CBL

0
Why Dillard's (DDS) is Poised to Beat Earnings Estimates Again

2018-08-14 zacks
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Dillard's (DDS - Free Report) , which belongs to the Zacks Retail - Regional Department Stores industry.
DDS

21
Einhorn's Greenlight cuts back many top holdings, slices Apple

2018-08-14 channelnewsasia
Billionaire investor David Einhorn, whose Greenlight Capital is posting some of the hedge fund industry's worst returns, cut back several long-term holdings including Apple Inc , Voya Financial Inc and Consol Energy Inc , a filing made on Tuesday shows.
DDT DDS CNX.WI AZO DLTR TJX CEIX.WI VOYA MU AAPL DG GPS URBN ATHN FIVE CEIX CNX

22
Einhorn's Greenlight cuts back many top holdings, slices Apple

2018-08-14 reuters - 1
BOSTON (Reuters) - Billionaire investor David Einhorn, whose Greenlight Capital is posting some of the hedge fund industry’s worst returns, cut back several long-term holdings including Apple Inc (AAPL.O), Voya Financial Inc (VOYA.N) and Consol Energy Inc (CEIX.N), a filing made on Tuesday shows.
DDT DDS CNX.WI AZO DLTR TJX CEIX.WI VOYA MU AAPL DG GPS URBN ATHN FIVE CEIX CNX

21
RPT-Einhorn's Greenlight cuts back many top holdings, slices Apple

2018-08-14 reuters
BOSTON, Aug 14 (Reuters) - Billionaire investor David Einhorn, whose Greenlight Capital is posting some of the hedge fund industry’s worst returns, cut back several long-term holdings including Apple Inc, Voya Financial Inc and Consol Energy Inc, a filing made on Tuesday shows.
DDT DDS CNX.WI AZO DLTR TJX CEIX.WI VOYA MU AAPL DG GPS URBN ATHN FIVE CEIX CNX

3
Earnings Preview: What's In Store For Macy's

2018-08-13 seekingalpha
Macy's 2018 has had a good start to the year, and second quarter earnings could reinforce positive trends in comps and margins.
DDS KSS M

16
Top Analyst Upgrades and Downgrades: AECOM, CyberArk, Dillard’s, Hasbro, Mattel, Newell, Papa John’s, Shopify, Snap, Tesla and More

2018-08-08 247wallst
Stocks were indicated to open marginally lower on Wednesday after China matched tariffs in the ongoing trade war. Investors have seen a strong earnings season, with more than 70% of the companies exceeding expectations and 80% of the S&P 500 having reported. Still, the volatility in 2018 has created less rewarding trades by buying the dips than had been so reliable in prior years. Many investors also are trying to decide how they want their investments positioned ahead of the midterm elections and with international trade concerns.
WFCNP ANDE BECN FND CYBR CUKPF ACM CCL DXC.WI MS DXC WFC DDS CARG CCL CUK HOG MAT HAS XRAY TRI

7
Dillard's (DDS) to Report Q2 Earnings: What's in the Offing?

2018-08-06 zacks
Dillard’s, Inc. (DDS - Free Report) is expected to release its second-quarter fiscal 2018 results on Aug 9. The company has an average trailing four-quarter miss of 49.9% even though it has delivered a positive earnings surprise in three quarters. The Zacks Consensus Estimate, presently pegged at a loss of 47 cents for the impending quarter, has widened in the past 30 days. However, the consensus mark reflects an improvement from a loss per share of 58 cents in second-quarter 2017.
DDS MKGAF JWN MKGAY FL BGSF BOOT

2
Top Ranked Growth Stocks to Buy for July 23rd

2018-07-23 zacks
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 23rd:
ODFL DDS ODLF XCRA

1
Zacks.com featured highlights include: Bunge, NOW, Dean Foods, Cooper Tire and Dillard's

2018-07-20 zacks
Chicago, IL – July 20, 2018 - Stocks in this week’s article Bunge Limited (BG - Free Report) , NOW Inc. (DNOW - Free Report) , Dean Foods Company (DF - Free Report) , Cooper Tire & Rubber Company (CTB - Free Report) and Dillard’s, Inc. (DDS - Free Report) .
DDS WLL KDP NOW BGEPF BG DNOW

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 254067101